Abstract
Introduction

Interleukin-1␤ (IL-1␤) is a prototypical multifunctional cytokine that plays an important role in intestinal inflammation of Crohn's disease (CD) and other inflammatory conditions of the gut
. CD is an immune mediated disorder characterized by chronic, relapsing inflammation of the gastrointestinal tract [4] . [5] . [7, 9, 10] . Thus, IL-1␤ has been identified as an important pro-inflammatory mediator of CD and therapeutic strategies to inhibit IL-1␤ are being explored [3, 8] . [11] . The bi-lipid apical membrane of the enterocytes is an effective barrier against transcellular permeation of passively absorbed hydrophilic substances present in the lumen [11, 12] [11, 12] . It 
IL-1␤ is markedly elevated in intestinal tissue and serum of CD patients and a correlation between increasing levels of IL-1␤ and increasing severity of intestinal inflammation has been demonstrated in patients with CD
An imbalance in IL-1␤ levels and its naturally occurring antagonist
IL-1 receptor antagonist (IL-1ra) occurs in CD patients such that there is an excess of pro-inflammatory and deficiency of anti-inflammatory forms of IL-1 [6-8]. IL-1␤ gene polymorphism also exists in CD patients that determine the severity of intestinal inflammation in the affected patients
An integral function of epithelial cells lining the intestinal tract is to act as a physical and functional barrier against noxious substances present in the intestinal lumen
. The intercellular tight junctions (TJs) that encircle the enterocytes at the apico-lateral membrane border act as a barrier against permeation of hydrophilic substances in-between cells (referred to as paracellular barrier function)
is well established that patients with CD have a defective
Cell cultures
Caco-2 cells (passage 18) 
Determination of epithelial monolayer resistance and paracellular permeability
An epithelial voltohmeter (World Precision Instruments, Sarasota, FL, USA) was used for measurements of the transepithelial electrical resistance (TER) of the filter-grown Caco-2 intestinal monolayers as previously
reported [31] . The effect of IL-1␤ on Caco-2 paracellular permeability was determined using an established paracellular marker inulin (m.w. ϭ 5000 g/mol) [32] . For determination of mucosal-to-serosal flux rates of inulin, Caco-2-plated filters having epithelial resistance of 400-500 ⍀ . cm 2 were used. Known concentrations of permeability marker (2 M) and its radioactive tracer were added to the apical solution. Low concentrations of permeability marker were used to ensure that negligible osmotic or concentration gradient was introduced.
Assessment of protein expression by Western blot analysis
Caco-2 monolayers were treated with IL-1␤ (10 
Quantification of gene expression using real-time PCR
The real-time PCRs were carried out using ABI prism 7900 sequence detection system and Taqman universal PCR master mix kit (Applied Biosystems, Branchburg, NJ, USA) as previously described [32, 33] Fig. 2A and B) [20, 32] . IL-1␤ caused a progressive drop in Caco-2 TER and an increase in transepithelial flux of inulin starting at about 12 hrs ( Fig. 2A and  B) . The ERK1/2 inhibitor PD98059 (100 M) inhibited the IL-1␤-induced activation of ERK1/2 (Fig. 2C) and prevented the drop in TER (Fig. 2D ) and the increase in inulin flux (Fig. 2E) (Fig. 3A) . The knockdown of ERK1/2 inhibited the IL-1␤-induced drop in Caco-2 TER (Fig. 3B) and increase in inulin flux (Fig. 3C) Figure 4A and [20] and increase in inulin flux (Fig. 4C) . The inhibition of ERK1/2 activity with pharmacologic inhibitor PD 98059 (100 M) inhibited the IL-1␤-induced increase in MLCK mRNA and protein expression (Fig. 4B and D) . The siRNAinduced knockdown of Caco-2 ERK1/2 also inhibited the IL-1␤-induced increase in MLCK mRNA and protein level (Fig. 4E and F) . These findings indicated that ERK1/2 signalling pathway was involved in IL-1␤ regulation of MLCK mRNA and protein expression. [25, 35] [32, 36] Fig. 6A-C Fig. 7B and C) . In contrast, siRNA-induced knockdown of Elk-1 (Fig. 8A) Fig. 9 ). promoter activity, the binding site B was mutated via site-directed mutagenesis. The mutation of site B inhibited the increase in MLCK -313 promoter activity (Fig. 11D) (Fig. 11E) . In combination, these data indicated that Elk-1 binding site B located within the minimal promoter region was the [20] . In these studies, the inhibition of MLCK protein expression or activity prevented the IL-1␤-induced increase in Caco-2 TJ permeability [20] . [32, 37, 38] . In contrast, anti-inflammatory cytokine IL-10 causes an enhancement in the epithelial TJ barrier function [39, 40] . The cytokineinduced alteration in intestinal TJ barrier has been shown to be an important pathogenic factor in the development of intestinal inflammation in murine models of intestinal inflammation [33] 
IL-1␤ induces MLCK promoter activation
(A) Time-course effect of IL-1␤ (10 ng/ml) on Caco-2 ERK1/2 phosphorylation (total ERK1/2 was used for equal protein loading). (B) Time-course effect of IL-1␤ on ERK1/2 activity was determined by ELISA-based in vitro kinase activity using MBP as the substrate. IL-1␤ caused a timedependent increase in Caco-2 ERK1/2 activity (means Ϯ S.E., n ϭ 4). *P Ͻ 0.001 versus control.
Fig. 2 Effect of ERK1/2 inhibition by pharmacologic inhibitor (PD-98059) (100 M) on Caco-2 ERK1/2 activity, TER, and paracellular permeability. (A) The effect of IL-1␤ (10 ng/ml) on Caco-2 TER and (B) mucosal-to-serosal flux of paracellular marker inulin (2 M) were measured sequentially over the 72-hr experimental period as described in the section 'Materials and methods'. IL-1␤ caused a time-dependent drop in Caco-2 TER and increase in paracellular permeability to inulin (C) PD-98059 (100 M) pre-treatment inhibited the IL-1␤-induced increase in ERK1/2 in vitro kinase activity. *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤. (D) PD-98059 prevented the IL-1␤-induced drop in Caco-2 TER. *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤. (E) pre-treatment with PD-98059 prevented the IL-1␤ increase in mucosal-to-serosal inulin flux (means Ϯ S.E., n ϭ 5). *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤ treatment.
Fig. 3 Effect of siRNA-induced ERK1/2 knockdown on IL-1␤-induced increase in Caco-2 TJ permeability. (A) ERK1/2 siRNA transfection resulted in a near complete depletion in ERK1/2 protein expression as determined by Western blot analysis. (B) ERK1/2 siRNA transfection prevented the IL-1␤-induced drop in Caco-2 TER. (C) ERK1/2 siRNA transfection prevented the IL-1␤-induced increase in inulin flux (means Ϯ S.E., n ϭ 5). *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤ treatment.
AP-1, Elk-1 and STAT-1 may be involved in IL-1␤ and ERK1/2 regulation of various biological activities
. IL-1␤ treatment of Caco-2 cells resulted in an activation of Elk-1 and AP-1 but not STAT-1 (
), suggesting that AP-1 or Elk-1 (but not STAT-1) may be involved in IL-1␤ modulation of MLCK gene expression. Next, the involvement of AP-1 or Elk-1 in IL-1␤-induced increase in MLCK mRNA and protein was determined by selective knockdown of AP-1 or Elk-1 via siRNA transfection. The siRNA-induced knockdown of AP-1 (Fig. 7A) did not affect the IL-1␤-induced increase in MLCK gene or protein level (
almost completely inhibited the IL-1␤-induced increase in Caco-2 MLCK mRNA and protein levels (Fig. 8B and C). The siRNA-induced knockdown of Elk-1 also inhibited the IL-1␤-induced drop in Caco-2 TER (Fig. 8D) and increase in inulin flux
Fig. 4 ERK1/2 inhibition prevented the IL-1␤-induced up-regulation of Caco-2 MLCK. (A) Time-course effect of IL-1␤ on Caco-2 MLCK protein expression (␤-actin was used as an internal control for protein loading). (B) IL-1␤ treatment caused an increase in Caco-2 MLCK mRNA. ERK1/2 inhibitor PD-98059 prevented the increase in MLCK mRNA levels. MLCK mRNA level was expressed relative to the control level which was assigned a value of 1. The average copy number of MLCK mRNA in controls was 4.63 ϫ 10 11 (means Ϯ S.E., n ϭ 5). *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤ treatment. (C) MLCK siRNA transfection prevented the IL-1␤-induced drop in Caco-2 TER. (D) MLCK siRNA-induced knockdown prevented the IL-1␤-induced increase in inulin flux (means Ϯ S.E., n ϭ 5). *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤ treatment. (E) ERK1/2 inhibitor PD-98059 prevented the IL-1␤-induced up-regulation of MLCK protein expression. Effect of siRNA ERK1/2 transfection on IL-1␤-induced increase in MLCK mRNA level (F) and increase in MLCK protein expression (G). siRNA-induced knockdown of ERK1/2 prevented the IL-1␤-induced increase in MLCK mRNA and MLCK protein levels (means Ϯ S.E., n ϭ 4). *P Ͻ 0.001 versus control; **P Ͻ 0.001 versus IL-1␤ treatment.
Fig. 5 IL-1␤ effect on MLCK promoter activity. IL-1␤ effect on the activity of the full-length MLCK promoter region (2091bp) in Caco-2 monolayers. pGL-3 basic vector containing the MLCK promoter region was transfected into the filter-grown Caco-2 cells. Caco-2 cells were treated with IL-1␤ (10 ng/ml) for 6 hrs. The MLCK promoter activity was determined by the luciferase assay and expressed as relative luciferase activity (means Ϯ S.E., n ϭ 8). *P Ͻ 0.0001 versus control. (Fig. 8E). Together, these results indicated that Elk-1 was required for the IL-1␤-induced increase in MLCK gene and protein expression and increase in Caco-2 monolayer TJ permeability. Next, the involvement of ERK1/2 signalling pathway on Elk-1 activation was determined. The inhibition of IL-1␤-induced activation of ERK1/2 by PD-98059 (100 M) inhibited the activation of Elk-1 (
Elk-1 regulates the MLCK promoter activity
Discussion
The cellular and molecular mechanisms that mediate IL-1␤ regulation of intestinal epithelial TJ barrier remain unclear. Previous studies from our laboratory indicated that the IL-1␤-induced increase in Caco-2 monolayer TJ permeability was mediated by an increase in MLCK protein level and enzymatic activity
